南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
NCI-H1155(人非小细胞肺癌细胞)
CBP60052 | |
I. General information | |
Synonyms: | NCI-H1155 |
Background: | This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lymph node metastasis obtained from a patient prior to therapy. |
Species: | Homo sapiens, human |
Tissue: | lung; derived from metastatic site: lymph node |
Disease: | carcinoma; non-small cell lung cancer |
Gender: | male,36 years, Caucasian |
Morphology: | epithelial |
Growth Mode: | clusters in suspension |
DNA Profile: | Amelogenin: X CSF1PO: 12 D13S317: 14 D16S539: 9 D5S818: 10 D7S820: 8 THO1: 6 TPOX: 8 vWA: 15 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
BEGM(Lonza CC-3170)+10%FBS NCI-H1155完全培养基,#CBP60052M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Genes Expressed: | neuromedin B (NMB) |
Cellular Products: | neuromedin B (NMB) |
Comments: | The cells are able to synthesize the peptide NMB at 0.2 pmol/mg protein, but not the gastrin releasing peptide (GRP). For more information, please contact Cobioer (4008-750-250). |
扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号